Navigation Links
Novel plague virulence factor identified

Researchers at Duke University Medical Center have identified a previously unknown family of virulence factors that make the bacterium responsible for the plague especially efficient at killing its host.

In the process, the team not only demonstrated that the use of the common roundworm is a valid model for studying the virulence of Yersinia pestis, the bacterium that causes plague. They also showed that the interaction between Y. pestis and the worm is quite similar to what occurs in mammals, including humans. The work indicates that the pathogen may use similar virulence mechanisms to infect evolutionary disperse organisms.

These findings are important, the researchers continued, since the pathogenesis system using the Caenorhabditis elegans worm can accelerate the process of better understanding Y. pestis pathogenesis. The shorter time and increased ease of experimentation can be especially important, the researchers continued, given potential use of Y. pestis as a biological weapon, they said.

The results of the Duke research will appear Aug. 26, 2005, in the on-line edition of European Molecular Biology Organization (EMBO) Reports to be published in print in October. The research was supported by the National Institutes of Health's National Institute of General Medical Science, the Southeast Regional Center for Emerging Infections and Biodefense (SERCEB) and the Duke Center for Translational Research.

"Our experiments have demonstrated how closely the Y. pestis-C. elegans model we developed mimics what happens when Y. pestis infects mammals," said Duke microbiologist Alejandro Aballay, Ph.D., lead researcher of the team. "This system should help speed the characterization of both pathogen and host functions that potentially can be targeted for intervention."

The Y. pestis bacterium primarily infects wild rodents, such as mice, rats and squirrels. It is usually transmitted by fleas, which spread the infection as they feed o n the blood of mammals. There are different forms of plague in humans -- bubonic, pneumonic and septicemic -- depending on site of infection; and infections in humans are highly lethal if not immediately treated.

"Dr Aballay has developed a new model for dissecting the ways pathogens such as the plague can infect and kill their hosts," said Pamela Marino, Ph.D., scientist at the National Institute of General Medical Science. "This creative approach should improve our ability to develop new medicines to treat such diseases."

Aballay has used the C. elegans, a worm commonly found in the soil, as a model to study the virulence mechanisms of other bacteria besides plague. The worm is an ideal model for genetic studies, he said, because it takes only three days to develop from an embryo to an adult capable of reproducing. Also, scientists can easily manipulate specific genes in the worm, and in contrast to other animal models, large quantities of the worms can be grown quickly and can even be frozen and used later.

"C elegans lives in the soil, so it continually comes into contact with bacteria and other microbes," Aballay said. "It has a highly developed system for not only recognizing bacteria, but also responding to them. The ability of its innate immune system to respond appropriately to specific bacteria is very similar to that of mammals."

Aballay tested Y. pestis in his model because another research team recently reported that the bacterium killed C. elegans by creating a "biofilm" over the worm's pharynx, causing it to die of starvation. Since mammals infected with Y. pestis do not die in this manner, Aballay believed that other virulence factors were involved in infecting the worm.

"We thought that a Y. pestis strain (known as KIM5) that lacks the genes (hmsHFRS operon) required for biofilm formation could still enter the worm's digestive system and eventually kill it by using a method different from food blockage," Aball ay explained. "We did in fact show that as Y. pestis lacking the hmsHFRS operon accumulated in the intestine causing a persistent and lethal infection."

The researchers then screened a library of almost 1,000 Y. pestis mutants and found that six virulence factors are crucial for the bacterium to have full virulence. Of the six virulence factors, three are also required for infections in mammals. One of these factors is similar to an exported protein of Salmonella enterica. In a study http://www.dukemednews.org/news/article.php?id=7647 published last year, Abalallay showed that Salmonella uses similar virulence factors to infect both mammals and C. elegans.

"The protein produced by this new Y. pestis virulence-related gene belongs to a family of uncharacterized proteins found exclusively in pathogenic enterobacteria," Aballay said. "This work links for the first time this particular family of bacterial proteins to virulence and we have done so by using a C. elegans pathogenesis system and a new mouse model of plague."

Aballay said that these types of conserved virulence factors may regulate innate immunity in a broad variety of hosts, including C. elegans, fleas and mammals.

"The importance of our work is that it will permit us to use a model whose genetics can be easily manipulated as a viable alternative not only for the identification of novel Y. pestis virulence factors but also to study conserved innate immune responses to the bacterium," Aballay said. "This may help us in developing strategies to protect humans from the plague."

Since the KIM5 strain of Y. pestis is well characterized and has a lower biosafety ranking than other infectious or toxic agents, Aballay believes that it will much easier for research laboratories to conduct research on virulence and innate immunity.

Other members of the research team were Duke's Katie Styer, Gregory Hopkin s, and Richard Frothingham, as well as Sara Schessar Bartra and Gregory Plano, University of Miami School of Medicine.


'"/>

Source:Duke University Medical Center


Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Enzyme Shows Potential As An Anti-HIV Target
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. Discovery Could Lead To Novel Approaches In HIV Treatment
7. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
8. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Novel live reporting system to track cells
11. Field of beams - Novel system uses polarized light pulses to reveal crop health
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... 23, 2016 ReportsnReports.com adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology: